Watanabe J, Kagawa Y, Chida K, et al. Phase III trial of short-course radiotherapy followed by CAPOXIRI versus CAPOX in locally advanced rectal cancer: the ENSEMBLE trial. ESMO Gastrointestinal Oncology. 2023;1:9-14.
Miyasato Y, Oba K, Masuda I, Mukoyama M. Investigation of the effect of visceral fat on the chronic kidney disease development and progression in medical checkup participants. 29th Scientific Meeting of the International Society of Hypertension (ISH), Kyoto, Japan, October 12-16, 2022.
Fuyama K, Ogawa M, Mizusawa J, Oba K. Impact of correlations between prioritized outcomes on the net benefit and its estimate by generalized pairwise comparisons, WNAR/IMS, Online, 2022, June 10-15, 2022.
Oba K, Paoletti X, Bang YJ, et al. Progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in advanced/recurrent gastric cancer (AGC) treatment: Individual-patient-data (IPD) based meta-analysis of randomized trials. Annual Meeting of ASCO2020, Online, June 4-6, 2020.
Asano-Inagaki A, Fukui C, Igarashi A, Sakka M, Noguchi-Watanabe M, Eltaybani, S, Takeuchi Y, Yamamoto-Mitani N. The effectiveness of homecare nursing use to reduce the incidence of potentially avoidable hospitalization among community-dwelling older adults in Japan : A 12-month prospective cohort study. IAGG Asia/Oceania Regional Congress 2023, Yokohama, 2023 Jun.
Kato L, Eltaybani S, Shinohara M, Igarashi A, Sumikawa Y, Inagaki A, Takeuchi Y, Yamamoto-Mitani N. Prognostic effect of body mass index on the incidence of unfavorable physical health outcomes among older adults receiving home care nursing: A prospective cohort study. IAGG Asia/Oceania Regional Congress 2023, Yokohama, 2023 Jun.
Kumamaru H, Takeuchi Y, Kohsaka S, Matsui H, Yasunaga H, Miyata H. Comparative effectiveness of First-line SGLT2 inhibitor use on heart failure hospitalization among patients with type 2 diabetes mellitus; A target trial emulation (Poster presentation). 38th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. 2022 Aug, Copenhagen/Online.
Takeuchi Y, Iwagami M, Ono S, Yasunaga H. Serious adverse effects after COVID-19 vaccination in Japan: Analysis using administrative claims data linked with vaccination registry. 14th Asian Conference on Pharmacoepidemiology. 2022 Oct, Tainan/Online.
Takada M, Shigehira Saji, Takayuki Ueno, Norikazu Masuda, Hiroshi Ishiguro, Takanori Ishida, Toshiaki Saeki, Shigeru Imoto, Shinji Ohno, Yoshinori Ito, Hiroji Iwata, Tomoharu Sugie, Kenjiro Aogi, Hirofumi Mukai, Shin Takayama, Nobuaki Sato, Yuichiro Kai, Masahiro Kitada, Yutaka Matsuyama, Masakazu Toi. Adjuvant S-1 plus endocrine therapy for estrogen receptor-positive, HER2-negative, primary breast cancer: update overall survival analysis from the POTENT trial. SABCS2022. 45th San Antonio Breast Cancer Symposium. 12/6/2022 - 12/10/2022.
Yoshikuni Kawaguchi, Ryuichi Kita, Toru Kimura, Tadatoshi Takayama, Namiki Izumi, Masatoshi Kudo, Shuichi Kaneko, Naoki Yamanaka, Masahumi Inomata, Mitsuo Shimada, Hideo Baba, Kazuhiko Koike, Masao Omata, Masatoshi Makuuchi, Yutaka Matsuyama, Norihiro Kokudo, Kiyoshi Hasegawa. Medical Expenditures and Treatment Efficacy of Patients who had Initial Hepatocellular Carcinoma and Underwent Surgery or Radiofrequency Ablation: Accompanying Research of the SURF Trial. ESMO2022.
Tatsuya Yamashita, Yoshikuni Kawaguchi, Shuichi Kaneko, Tadatoshi Takayama, Namiki Izumi, Naoki Yamanaka, Masatoshi Kudo, Mitsuo Shimada, Masafumi Inomata, Hideo Baba, Kazuhiko Koike, Masao Omata, Masatoshi Makuuchi, Yutaka Matsuyama, Norihiro Kokudo, Kiyoshi Hasegawa. A multicenter, non-randomized, controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF-Cohort Trial): Analysis of overall survival. 2022 ASCO Annual Meeting (June 3 - June 7, 2022).
Yutaka Matsuyama. Measuring PROs for people with Parkinson’s in clinical trials. Takeda Expert Conference on Parkinson’s Disease. Tokyo. 2020/12/12.
Hagiwara Y. Estimation of modified effectiveness in confirmatory cancer clinical trials using dynamic marginal structural models. PeSeTo International Symposium on Public Health 2016, Tokyo, Japan, March 15, 2016.
Shinozaki T, Matsuyama Y. (November 2014). “Doubly robust estimation of a marginal structural model in the exposed population.” At: Kyoto International Conference on Modern Statistics in the 21st Century, Kyoto, Japan. Chair: Manabu Iwasaki. (Invited)
Matsuyama Y. Semiparametric estimation of treatment effect in a randomized clinical trial with missing data. International Symposium Incomplete Data Analysis and Causal Inference, Osaka University, 22-23 September 2013.
Matsuyama Y and Tanaka Y. Estimation of treatment effect adjusting for non-compliance using the intensity score method. 科学研究費補助金（基盤研究 (A) (1)）シンポジウム「不完全データ解析とその周辺」 東京．2006/1/23.
Shinozaki T, Matsuyama Y. Data analysis on real world data: an overview. In: Sudoh, O. (editor). Epidemiologic Research on Real World Medical Data in Japan. Switzerland: Springer International Publishing, 2019 (forthcoming).
Oba K, Paoletti X. Evaluation of Surrogate Endpoints using a Meta-Analysis Approach with Individual Patient Data: Summary of a Gastric Cancer Meta-Analysis Project. In: Matsui S, Crowley J(Eds.) Frontiers of Biostatistical Methods and Applications in Clinical Oncology. Springer Singapore, Singapore, 2017
Buyse M, Molenberghs G, Paoletti X, Oba K, Alonso A,Van der Elst W, Burzykowski T. Statistical evaluation of surrogate endpoints in cancer clinical trials. In: Oncology Clinical Trials: Successful Design, Conduct and Analysis. Second Edition, Demos Medical Publishing, NY, 2017